Stay updated on Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Sign up to get notified when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.

Latest updates to the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect new information regarding a study on pancreatic cancer, including new drug names and collaborators, as well as revised dates for the study timeline. Significant details about the study's design and objectives have been removed.SummaryDifference26%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.